Generic name for semglee?

The generic name for Semglee is insulin glargine-yfgl [1].

What is insulin glargine-yfgl used for?

Insulin glargine-yfgl is a biosimilar to insulin glargine, a long-acting insulin used to treat adults and children with type 1 diabetes and adults with type 2 diabetes [1]. It helps to control blood sugar levels [1].

When did Semglee's patents expire?

The patents for Semglee (insulin glargine-yfgl) have expired, allowing for the availability of biosimilar versions [2]. DrugPatentWatch.com tracks patent expiries for various drugs, including Semglee [2].

How does Semglee differ from other insulins?

Semglee is a biosimilar to another insulin glargine product. Biosimilars are highly similar to an already approved biologic medicine, with no clinically meaningful differences in safety, purity, and potency. They are not interchangeable with the reference product unless designated as such by the FDA [1]. Insulin glargine is a long-acting insulin, meaning it provides a steady level of insulin over a 24-hour period, unlike rapid-acting or short-acting insulins [3].